Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 1385-1389, 2012.
Artigo em Chinês | WPRIM | ID: wpr-309348

RESUMO

<p><b>OBJECTIVE</b>To investigate the effects of complement inhibiting component of Ephedra sinica on immunological inflammation following acute spinal cord injury (SCI) in rats.</p><p><b>METHODS</b>The complement inhibiting component of Ephedra sinica was isolated by multiple precipitation steps and thin layer chromatography, and then the activity was analyzed. Fifty healthy SD rats were selected and randomly divided into the control group and the experimental group, 25 in each group. Induction of SCI was performed following a modified Allen's weight-drop method. The complement inhibiting component from Ephedra sinica (15 mg/kg) dissolving in 5 mL normal saline was immediately administered by gastrogavage after SCI, once daily. Equal volume of normal saline was administered to rats in the control group by gastrogavage. Hematoxylin and eosin (H&E) staining and C3 immunohistochemical staining were performed in SCI tissue at 12 h, day 1, 3, 7, and 14 after SCI. C3 positive expressions and myeloperoxidase (MPO) activity were assessed. Intercellular adhesion molecule-1 (ICAM-1) mRNA expression level was evaluated by Real-time PCR technique.</p><p><b>RESULTS</b>C3 positive expression, MPO activity, and ICAM-1 mRNA level were significantly weaker in the Ephedra sinica group than in the control group at all time points (12 h, day 1, day 3, day 7, and day 14 after SCI) (P < 0.01, P < 0.05).</p><p><b>CONCLUSIONS</b>There existed complement system activation following acute SCI. The complement inhibiting component of Ephedra sinica significantly reduced immunological inflammation after SCI, and played an important role in secondary SCI.</p>


Assuntos
Animais , Ratos , Ativação do Complemento , Alergia e Imunologia , Inativadores do Complemento , Farmacologia , Ephedra sinica , Química , Inflamação , Alergia e Imunologia , Ratos Sprague-Dawley , Traumatismos da Medula Espinal , Alergia e Imunologia , Metabolismo , Patologia
2.
Chinese Journal of Traumatology ; (6): 49-53, 2005.
Artigo em Inglês | WPRIM | ID: wpr-338645

RESUMO

<p><b>OBJECTIVE</b>To determine the effects of recombinant soluble complement receptor type I (sCR1) on the immune inflammatory reaction in acute spinal cord injury tissue of rats and its protective effects.</p><p><b>METHODS</b>SD rat models of acute spinal cord injury were prepared by modified Allen's method. The motor function of the rat lower extremities in sCR1 group and normal saline (NS) group was evaluated by the tiltboard experiment at 12 h, 1 d, 3 d, 7 d, and 14 d. The neutrophil infiltration and C3c positive expression were observed. The myeloperoxidase activity was assessed in the injury tissue at 12 h, 1 d, 3 d, 7 d, and 14 d after injury in the two groups.</p><p><b>RESULTS</b>The motor function of rat in sCR1 group at 3 d, 7 d, and 14 d was obviously better than that in NS group (P<0.01, P<0.01, P<0.01). C3c positive expression in sCR1 group at each time point after injury was obviously less than that in NS group (P<0.01). The myeloperoxidase activity in sCR1 group at each time point after injury was obviously less than that in NS group (P<0.01).</p><p><b>CONCLUSIONS</b>Recombinant soluble complement receptor type I (sCR1) can lessen the immune inflammatory reaction in acute spinal cord injury tissue and relieve secondary spinal cord injury by inhibiting the activation of the complement system.</p>


Assuntos
Animais , Ratos , Modelos Animais de Doenças , Imuno-Histoquímica , Inflamação , Peroxidase , Distribuição Aleatória , Ratos Sprague-Dawley , Receptores de Complemento , Usos Terapêuticos , Proteínas Recombinantes , Usos Terapêuticos , Traumatismos da Medula Espinal , Tratamento Farmacológico , Patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA